INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,332 | -22.5% | 390 | 0.0% | 0.01% | -14.3% |
| Q2 2023 | $15,905 | +9.4% | 390 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $14,536 | +6.8% | 390 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $13,607 | -38.2% | 390 | 0.0% | 0.01% | -33.3% |
| Q3 2022 | $22,000 | +10.0% | 390 | 0.0% | 0.02% | +5.0% |
| Q2 2022 | $20,000 | -28.6% | 390 | 0.0% | 0.02% | -20.0% |
| Q1 2022 | $28,000 | -39.1% | 390 | 0.0% | 0.02% | -39.0% |
| Q4 2021 | $46,000 | -11.5% | 390 | 0.0% | 0.04% | -10.9% |
| Q3 2021 | $52,000 | -17.5% | 390 | 0.0% | 0.05% | -16.4% |
| Q2 2021 | $63,000 | – | 390 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |